https://ojs.bbwpublisher.com/index.php/JCNR <p align="justify"><em>Journal of Clinical and Nursing Research (JCNR) </em>is an international, peer reviewed and open access journal that seeks to promote the development and exchange of knowledge which is directly relevant to all clinical and nursing research and practice. Articles which explore the meaning, prevention, treatment, outcome and impact of a high standard clinical and nursing practice and discipline are encouraged to be submitted as original article, review, case report, short communication and letters. The covered topics include, but are not limited to: development of clinical and nursing research, evaluation, evidence-based practice and scientific enquiry; patients and family experiences of health care; clinical and nursing research to enhance patient safety and reduce harm to patients; ethics; clinical and nursing history; medicine.</p> <p align="justify">&nbsp;</p> en-US info@bbwpublisher.com (Andy Song) info@bbwpublisher.com (Michelle) Thu, 16 Jan 2025 00:00:00 +0800 OJS 3.1.2.0 http://blogs.law.harvard.edu/tech/rss 60 https://ojs.bbwpublisher.com/index.php/JCNR/article/view/9387 <p>Naru Sanwei Pill, also known as Naru-3, a Mongolian medicine originating from <em>Zhigao Pharmacopoeia</em>, is a classic prescription used in the treatment of rheumatism. It is composed of <em>Terminalia chebula</em>, processed <em>Aconitum kusnezoffii Reichb.</em>, and <em>Piper longum</em>, and is known for its effects in eliminating “mucus,” relieving pain, and reducing swelling, with significant efficacy in treating joint effusion and lumbar pain. In recent years, researchers have summarized its chemical components and pharmacological effects, and employed network pharmacology methods based on the core theory of Traditional Chinese Medicine quality markers (Q-Markers) to analyze and predict its markers. The results identified potential Q-Markers for Naru-3, providing a scientific basis for quality control and further research.</p> Ying En, Liang Xu, Jiaqi Yu Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/JCNR/article/view/9387 Tue, 21 Jan 2025 08:42:02 +0800 https://ojs.bbwpublisher.com/index.php/JCNR/article/view/9388 <p>Acute pulmonary edema is a leading cause of death in patients with preeclampsia. The authors reported a case of a pregnant woman at 25 weeks of gestation with severe preeclampsia complicated by pulmonary edema, who required an emergency cesarean section, posing a significant challenge to the anesthesiologist. The patient had developed Type 1 respiratory failure and needed supplemental oxygen with high-flow nasal oxygen. Due to contraindications for neuraxial anesthesia, the cesarean section was performed under general anesthesia. After induction of anesthesia, the patient’s hypoxemia worsened. Eventually, after treatment with fluid restriction, diuretics, and albumin, oxygenation improved gradually, and the procedure was performed successfully. Both the patient and the newborn had a good prognosis.</p> Yifan Tao, Guoxun Xu, Lu Yang Copyright (c) 2025 Author(s) https://ojs.bbwpublisher.com/index.php/JCNR/article/view/9388 Thu, 16 Jan 2025 15:11:24 +0800